We are live on
!
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$156M
1-Year Est. Return
14.89%
This Fund
S&P 500
This Quarter
Est. Return
+17.28%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.09%
AUM
$942M
AUM Growth
+$65.9M
(+7.5%)
Cap. Flow
-$40.6M
Cap. Flow
% of AUM
-4.31%
Top 10 Holdings %
Top 10 Hldgs %
17.62%
Holding
1,095
New
434
Increased
124
Reduced
144
Closed
391
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$20.3M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$20.1M |
| 3 |
Qualcomm
QCOM
|
+$13.7M |
| 4 |
Datadog
DDOG
|
+$9.59M |
| 5 |
ExxonMobil
XOM
|
+$8.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palo Alto Networks
PANW
|
+$20M |
| 2 |
Meta Platforms (Facebook)
META
|
+$18.9M |
| 3 |
Walt Disney
DIS
|
+$11.5M |
| 4 |
Skyworks Solutions
SWKS
|
+$9.77M |
| 5 |
Nike
NKE
|
+$9.74M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.27% |
| 2 | Consumer Discretionary | 12.98% |
| 3 | Healthcare | 12.92% |
| 4 | Financials | 8.55% |
| 5 | Industrials | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Karyopharm Therapeutics
KPTI
$42.9M
| $9.6K | ﹤0.01% |
+740
| New | +$9.97K |
|
|
AGEN
702
Agenus
AGEN
$355M
| $8.53K | ﹤0.01% |
+515
| New | +$8.53K |
|
703
Senseonics Holdings Inc
SENS
$499M
| $7.92K | ﹤0.01% |
695
-85
| -11% | -$971 |
|
704
Matinas BioPharma
MTNB
$2.93M
| $4.07K | ﹤0.01% |
+376
| New | +$4.24K |
|
705
AbbVie
ABBV
$454B
| – | – |
-3,500
| Closed | -$522K |
|
706
Airbnb
ABNB
$112B
| – | – |
-11,200
| Closed | -$1.54M |
|
|
ACLX
707
DELISTED
Arcellx
ACLX
| – | – |
-6,100
| Closed | -$219K |
|
708
ACM Research
ACMR
$5.38B
| – | – |
-14,300
| Closed | -$259K |
|
709
Accenture
ACN
$117B
| – | – |
-12,907
| Closed | -$3.96M |
|
710
Adobe
ADBE
$116B
| – | – |
-1,175
| Closed | -$599K |
|
|
ADAP
711
DELISTED
Adaptimmune Therapeutics
ADAP
| – | – |
-10,486
| Closed | -$8.18K |
|
712
Adaptive Biotechnologies
ADPT
$4.12B
| – | – |
-19,239
| Closed | -$105K |
|
713
Aflac
AFL
$58.4B
| – | – |
-11,551
| Closed | -$887K |
|
714
Affirm
AFRM
$27.7B
| – | – |
-315,579
| Closed | -$6.71M |
|
715
Agilon Health
AGL
$1.57B
| – | – |
-2,030
| Closed | -$901K |
|
716
AdaptHealth
AHCO
$782M
| – | – |
-14,600
| Closed | -$133K |
|
717
American International
AIG
$40.2B
| – | – |
-6,981
| Closed | -$423K |
|
718
Applied Industrial Technologies
AIT
$12B
| – | – |
-2,118
| Closed | -$327K |
|
719
Acadia Realty Trust
AKR
$2.88B
| – | – |
-43,895
| Closed | -$630K |
|
|
AKRO
720
DELISTED
Akero Therapeutics
AKRO
| – | – |
-5,634
| Closed | -$285K |
|
721
Albemarle
ALB
$16.3B
| – | – |
-9,720
| Closed | -$1.65M |
|
722
Align Technology
ALGN
$11.2B
| – | – |
-6,634
| Closed | -$2.03M |
|
723
Alkermes
ALKS
$8.05B
| – | – |
-16,400
| Closed | -$459K |
|
724
Allstate
ALL
$65.7B
| – | – |
-13,800
| Closed | -$1.54M |
|
725
Allogene Therapeutics
ALLO
$701M
| – | – |
-26,500
| Closed | -$84K |
|
Similar funds
MCM
MFG
AFW
ADBIC
HSM
FWM
PIA
CCP
Bayesian Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, Bayesian Capital Management held 1,095 positions worth $942M, up 7.5% from $876M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Bayesian Capital Management withdrew a net $40.6M in Q4 2023, closing 391 positions and reducing 144 holdings. Its most notable exit was Palo Alto Networks, an estimated $20M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Bayesian Capital Management opened a new position in State Street SPDR S&P 500 ETF Trust worth $21.5M.
- Bayesian Capital Management's largest Q4 2023 buy was State Street SPDR S&P 500 ETF Trust: 45,200 shares worth $21.5M.
- Bayesian Capital Management added most to Alibaba in Q4 2023, an estimated $20.3M increase.
- Bayesian Capital Management's biggest Q4 2023 reduction was Meta Platforms (Facebook), cutting an estimated $18.9M.
- Bayesian Capital Management fully exited Palo Alto Networks in Q4 2023, selling an estimated $20M.
- Bayesian Capital Management's ten largest holdings make up 18% of its $942M portfolio in Q4 2023.
- Bayesian Capital Management opened 434 new positions and closed 391 in Q4 2023.
- Bayesian Capital Management's portfolio value rose 7.5% quarter-over-quarter to $942M.
Based on Bayesian Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.